Cerebral and Cutaneous Involvements of Xanthoma Disseminatum Successfully Treated with an Interleukin-1 Receptor Antagonist: A Case Report and Minireview
Author
dc.contributor.author
Campero Soffia, Mario
Author
dc.contributor.author
Campero, Sebastián
Author
dc.contributor.author
Guerrero Peralta, Julia
Author
dc.contributor.author
Aouba, Aouba
Author
dc.contributor.author
Castro, Alex
Admission date
dc.date.accessioned
2016-07-06T14:02:29Z
Available date
dc.date.available
2016-07-06T14:02:29Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Dermatology 2016;232:171–176
en_US
Identifier
dc.identifier.other
DOI: 10.1159/000442522
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/139430
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
A young male presented with panhypopituitarism (including
diabetes insipidus) and temporal lobe epilepsy. A histology
specimen of cutaneous papules was diagnostic of non-
Langerhans histiocytosis. The diagnosis of xanthoma granulomata
was considered based on the clinical and brain MRI
findings. Brain lesions significantly worsened over time despite
radiotherapy until anakinra induced a complete clinical
and radiological remission of all active lesions. Although a
single case, the outcome of this patient with xanthoma disseminatum
treated with an interleukin-1 receptor antagonist
opens and strengthens new and recent physiopathogenic
and treatment perspectives for the otherwise difficultto-
treat non-Langerhans cell histiocytosis. Similar results
with anakinra have been observed in patients with Erdheim-
Chester disease and in multicentric reticulohistiocytosis.
Cerebral and Cutaneous Involvements of Xanthoma Disseminatum Successfully Treated with an Interleukin-1 Receptor Antagonist: A Case Report and Minireview